Literature DB >> 31796991

A role of cellular translation regulation associated with toxic Huntingtin protein.

Hiranmay Joag1,2, Vighnesh Ghatpande1, Meghal Desai1, Maitheli Sarkar1, Anshu Raina1, Mrunalini Shinde3, Ruta Chitale3, Ankita Deo3, Tania Bose4, Amitabha Majumdar5.   

Abstract

Huntington's disease (HD) is a severe neurodegenerative disorder caused by poly Q repeat expansion in the Huntingtin (Htt) gene. While the Htt amyloid aggregates are known to affect many cellular processes, their role in translation has not been addressed. Here we report that pathogenic Htt expression causes a protein synthesis deficit in cells. We find a functional prion-like protein, the translation regulator Orb2, to be sequestered by Htt aggregates in cells. Co-expression of Orb2 can partially rescue the lethality associated with poly Q expanded Htt. These findings can be relevant for HD as human homologs of Orb2 are also sequestered by pathogenic Htt aggregates. Our work suggests that translation dysfunction is one of the contributors to the pathogenesis of HD and new therapies targeting protein synthesis pathways might help to alleviate disease symptoms.

Entities:  

Keywords:  Functional-prion-like protein; Huntington’s disease; Orb2; Translation regulator

Mesh:

Substances:

Year:  2019        PMID: 31796991     DOI: 10.1007/s00018-019-03392-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  57 in total

Review 1.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

2.  A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.

Authors:  Jurre Hageman; Maria A Rujano; Maria A W H van Waarde; Vaishali Kakkar; Ron P Dirks; Natalia Govorukhina; Henderika M J Oosterveld-Hut; Nicolette H Lubsen; Harm H Kampinga
Journal:  Mol Cell       Date:  2010-02-12       Impact factor: 17.970

3.  Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.

Authors:  Marta Martinez-Vicente; Zsolt Talloczy; Esther Wong; Guomei Tang; Hiroshi Koga; Susmita Kaushik; Rosa de Vries; Esperanza Arias; Spike Harris; David Sulzer; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-04-11       Impact factor: 24.884

4.  Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach.

Authors:  David G Hay; Kirupa Sathasivam; Sönke Tobaben; Bernd Stahl; Michael Marber; Ruben Mestril; Amarbirpal Mahal; Donna L Smith; Ben Woodman; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

Review 5.  Huntington disease.

Authors:  Gillian P Bates; Ray Dorsey; James F Gusella; Michael R Hayden; Chris Kay; Blair R Leavitt; Martha Nance; Christopher A Ross; Rachael I Scahill; Ronald Wetzel; Edward J Wild; Sarah J Tabrizi
Journal:  Nat Rev Dis Primers       Date:  2015-04-23       Impact factor: 52.329

6.  Global changes to the ubiquitin system in Huntington's disease.

Authors:  Eric J Bennett; Thomas A Shaler; Ben Woodman; Kwon-Yul Ryu; Tatiana S Zaitseva; Christopher H Becker; Gillian P Bates; Howard Schulman; Ron R Kopito
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

7.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Authors:  J-M Lee; E M Ramos; J-H Lee; T Gillis; J S Mysore; M R Hayden; S C Warby; P Morrison; M Nance; C A Ross; R L Margolis; F Squitieri; S Orobello; S Di Donato; E Gomez-Tortosa; C Ayuso; O Suchowersky; R J A Trent; E McCusker; A Novelletto; M Frontali; R Jones; T Ashizawa; S Frank; M H Saint-Hilaire; S M Hersch; H D Rosas; D Lucente; M B Harrison; A Zanko; R K Abramson; K Marder; J Sequeiros; J S Paulsen; G B Landwehrmeyer; R H Myers; M E MacDonald; J F Gusella
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

8.  Suppression of protein aggregation by chaperone modification of high molecular weight complexes.

Authors:  John Labbadia; Sergey S Novoselov; John S Bett; Andreas Weiss; Paolo Paganetti; Gillian P Bates; Michael E Cheetham
Journal:  Brain       Date:  2012-03-06       Impact factor: 13.501

9.  Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease.

Authors:  Mark S Hipp; Chetan N Patel; Kirill Bersuker; Brigit E Riley; Stephen E Kaiser; Thomas A Shaler; Michael Brandeis; Ron R Kopito
Journal:  J Cell Biol       Date:  2012-02-27       Impact factor: 10.539

Review 10.  Pathways of cellular proteostasis in aging and disease.

Authors:  Courtney L Klaips; Gopal Gunanathan Jayaraj; F Ulrich Hartl
Journal:  J Cell Biol       Date:  2017-11-10       Impact factor: 10.539

View more
  6 in total

Review 1.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

2.  Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease.

Authors:  Mehdi Eshraghi; Pabalu P Karunadharma; Juliana Blin; Neelam Shahani; Emiliano P Ricci; Audrey Michel; Nicolai T Urban; Nicole Galli; Manish Sharma; Uri Nimrod Ramírez-Jarquín; Katie Florescu; Jennifer Hernandez; Srinivasa Subramaniam
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

Review 3.  The role of CPEB family proteins in the nervous system function in the norm and pathology.

Authors:  Eugene Kozlov; Yulii V Shidlovskii; Rudolf Gilmutdinov; Paul Schedl; Mariya Zhukova
Journal:  Cell Biosci       Date:  2021-03-31       Impact factor: 7.133

4.  Formation and persistence of polyglutamine aggregates in mistranslating cells.

Authors:  Jeremy T Lant; Rashmi Kiri; Martin L Duennwald; Patrick O'Donoghue
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

5.  Nucleolar stress controls mutant Huntington toxicity and monitors Huntington's disease progression.

Authors:  Michael Orth; Birgit Liss; Rosanna Parlato; Aynur Sönmez; Rasem Mustafa; Salome T Ryll; Francesca Tuorto; Ludivine Wacheul; Donatella Ponti; Christian Litke; Tanja Hering; Kerstin Kojer; Jenniver Koch; Claudia Pitzer; Joachim Kirsch; Andreas Neueder; Grzegorz Kreiner; Denis L J Lafontaine
Journal:  Cell Death Dis       Date:  2021-12-08       Impact factor: 8.469

6.  Structural transitions in Orb2 prion-like domain relevant for functional aggregation in memory consolidation.

Authors:  Javier Oroz; Sara S Félix; Eurico J Cabrita; Douglas V Laurents
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.